A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old | MicrobiomeTrials
A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2023-02-20Est. Completion: 2026-07-21
Enrollment target: 71 participants
Locations
Childrens Center for Digestive Health Care, LLC, Mobile, Alabama, United States
University of Utah/ Primary Childrens Hospital, San Francisco, California, United States
GI For Kids, Atlanta, Georgia, United States
Childrens Hospital of The Kings Daughters, Jackson, Mississippi, United States
The University of Chicago, Cleveland, Ohio, United States
National Research Centers, Norfolk, Virginia, United States
Women and Children's Health Research Institute, Edmonton, Alberta, Canada
London Health Sciences Centre Children's Hospital, London, Ontario, Canada
Hospital Universitario San Ignacio, Bogotá, Colombia
Fundacion Valle del Lili, Cali, Colombia
Centro Medico Imbanaco de Cali S.A, Cali, Colombia